序贯疗法和标准三联疗法治疗幽门螺杆菌阳性胃溃疡56例临床分析.docVIP

序贯疗法和标准三联疗法治疗幽门螺杆菌阳性胃溃疡56例临床分析 　　【摘要】 目的：研究标准三联疗法以及序贯疗法对于幽门螺杆菌阳性胃溃疡的实际治疗效果。方法：对照组使用标准三联疗法进行治疗，实验组则使用序贯疗法进行治疗，比较治疗效果，分析出现的不良反应以及胃溃疡实际改善状况。结果：实验组采用序贯疗法的幽门螺杆菌实际治疗有效率达到96.43%；对照组采用标准三联疗法幽门螺杆菌的实际治疗有效率为78.57%。实验组使用序贯疗法后患者的胃溃疡痊愈例数为12例，显效例数为10例，有效例数为5例，无效例数为1例，有效率达到了96.43%；对照组使用标准三联疗法后患者的胃溃疡痊愈例数为2例，显效例数为9例，有效例数为7例，无效例数为10例，有效率为64.29%。结论：序贯疗法作为一种治疗幽门螺杆菌阳性胃溃疡的创新方法，其具有很好的治疗效果，现如今的耐药菌株较少，可以进行临床大规模使用。 　　【关键词】序贯疗法；幽门螺杆菌阳性胃溃疡；标准三联疗法；临床分析 　　【Abstract】 Objective: To study the standard triple therapy and sequential therapy for the treatment of Helicobacter Pylori Positive Peptic ulcer. Methods: the control group using standard triple therapy, the experimental group used sequential therapy, therapeutic effect, adverse reaction and analysis of the actual condition of gastric ulcer. Results: the experimental group of the Helicobacter pylori sequential therapy of actual treatment effective rate 96.43%; control group with the treatment of standard triple therapy for Helicobacter pylori and the effective rate was 78.57%. The experimental group used sequential therapy in patients with gastric ulcer cured 12 patients were markedly effective, 10 patients were effective, 5 patients were ineffective cases, 1 cases, effective rate was 96.43%; the control group using standard triple therapy in patients with gastric ulcer healing after the number of cases is 2 cases, cured cases number of 9 cases, the effective number of cases to 7 cases, invalid cases to 10 cases, efficiency of 64.29%. Conclusion: sequential therapy as an innovative approach to the treatment of Helicobacter pylori positive gastric ulcer, which has a very good therapeutic effect, now resistant strains is less, can be large-scale clinical use. 　　【key words 】sequential therapy; Helicobacter pylori positive peptic ulcer; triple therapy; clinical analysis 　　【中图分类号】R726.12 【文献标识码】B【文章编号】1004-4949(2014)07-0049-02 　　 　　导致患者出现胃溃疡的主要致病因子是幽门螺杆菌，这已经得到了诺贝尔奖获得者的证实，也已经得到了广泛的认可，当患者感染幽门螺杆菌以后就会出现相应的炎症，患者胃部的腺体就会出现相应的剖坏，进而导致患者胃出现明显的萎缩，因而需要对患